Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04654923

GERAP's Epidemiological Survey on Perioperative Hypersensitivity Reactions

Perioperative hypersensitivity reactions are still associated with significant morbidity and mortality despite early recognition and use of epinephrine. The epidemiology of these reactions evolves over time and changes with clinical practice. The main objective is to study the epidemiology of these reactions over a 10-year period, including patient phenotype, reaction phenotype and outcome of the allergic work-up.

Recruiting

Interested in participating?

Request Info

Key information

Age range

7 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service d'anesthésie-réanimation - CHU de Strasbourg - France

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Adrien MARZIALE, MD

SUB_INVESTIGATOR

Alain FACON, MD

PRINCIPAL_INVESTIGATOR

Alice SERINGULIAN, MD

PRINCIPAL_INVESTIGATOR

Anaïs PIPET, MD

PRINCIPAL_INVESTIGATOR

Anca CHIRIAC, MD

PRINCIPAL_INVESTIGATOR

Aurélie GOUEL CHERON, MD

PRINCIPAL_INVESTIGATOR

Bertrand LEMAIRE, MD

PRINCIPAL_INVESTIGATOR

Béatrice CAVESTRI-MACIEJASZ, MD

PRINCIPAL_INVESTIGATOR

Carine BILLARD, MD

PRINCIPAL_INVESTIGATOR

Catherine NEUKIRCH, MD

SUB_INVESTIGATOR

Chantal KARILA, MD

PRINCIPAL_INVESTIGATOR

Charles DZVIGA, MD

PRINCIPAL_INVESTIGATOR

Charles TACQUARD, MD

CONTACT

[email protected]

33.3.69.55.16.08

Charles TACQUARD, MD

PRINCIPAL_INVESTIGATOR

Christelle PELLERIN, MD

PRINCIPAL_INVESTIGATOR

Christine FESSENMEYER, MD

PRINCIPAL_INVESTIGATOR

Christine MULLET, MD

SUB_INVESTIGATOR

Claire MAIHOL, MD

PRINCIPAL_INVESTIGATOR

Cyrille HOARAU, MD

PRINCIPAL_INVESTIGATOR

Cécile ROCHEFORT MOREL, MD

PRINCIPAL_INVESTIGATOR

Cédric DELZANNO, MD

PRINCIPAL_INVESTIGATOR

Daniela MUTI, MD

PRINCIPAL_INVESTIGATOR

David LEPAGE, MD

PRINCIPAL_INVESTIGATOR

Delphine MARIOTTE, MD

PRINCIPAL_INVESTIGATOR

Elleni VAIA, MD

PRINCIPAL_INVESTIGATOR

Emmanuelle AGUINET, MD

PRINCIPAL_INVESTIGATOR

Etienne BAUDOUIN, MD

SUB_INVESTIGATOR

Eva SERRANO, MD

PRINCIPAL_INVESTIGATOR

Florence LAKKIS-CASTELAIN, MD

PRINCIPAL_INVESTIGATOR

Georgia DALAMPIRA, MD

PRINCIPAL_INVESTIGATOR

Guillaume POUESSEL, MD

PRINCIPAL_INVESTIGATOR

Hafida GAOUAR, MD

PRINCIPAL_INVESTIGATOR

Isabelle ORSEL, MD

PRINCIPAL_INVESTIGATOR

Jean-Marc MALINOVSKY, MD, PhD

PRINCIPAL_INVESTIGATOR

Laurent GUILLEMINAULT, MD

PRINCIPAL_INVESTIGATOR

Luc COLAS, MD

SUB_INVESTIGATOR

Marion GOUITAA, MD

SUB_INVESTIGATOR

Marion VERDAGUER, MD

PRINCIPAL_INVESTIGATOR

Martine MORISSET, MD, PhD

PRINCIPAL_INVESTIGATOR

Morgan LE GUEN, MD

PRINCIPAL_INVESTIGATOR

Nathalie DIOT-JUNIQUE, MD

PRINCIPAL_INVESTIGATOR

Nicolas JUST, MD

SUB_INVESTIGATOR

Omar OUTTAS, MD

SUB_INVESTIGATOR

Pascal DEMOLY, MD, PhD

SUB_INVESTIGATOR

Paul-Michel MERTES, MD, PhD

CONTACT

[email protected]

33 3 69 55 04 44

Paul-Michel MERTES, MD, PhD

PRINCIPAL_INVESTIGATOR

Rodolphe STENGER, MD

SUB_INVESTIGATOR

Sabrina DESSARD, MD

SUB_INVESTIGATOR

Sandrine SELTZE, MD

PRINCIPAL_INVESTIGATOR

Sandrine TERCINET, MD

SUB_INVESTIGATOR

Solène HUSSER, MD

SUB_INVESTIGATOR

Sylvie DECAGNY, MD

PRINCIPAL_INVESTIGATOR

Sébastien FRANCHINA, MD

SUB_INVESTIGATOR

Sébastien LEFEVRE, MD

PRINCIPAL_INVESTIGATOR

Valérie RENAULD, MD

PRINCIPAL_INVESTIGATOR

Yann OLLIVIER, MD

PRINCIPAL_INVESTIGATOR

Yannick MEUNIER, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Minor and major subject
  • Subject having experienced a perioperative hypersensitivity reaction between January the 1st 2017 and December the 31st 2027.
  • Referred for an allegro-anesthetic workup
  • Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion criteria

  • Subject having expressed opposition to participating in the study
  • Inability to provide the subject with research information
  • Subject under guardianship or guardianship
  • Subject under safeguard of justice

Treatment and study plan

Primary outcomes

  1. Retrospective analysis of incidence of all perioperative hypersensitivity reactions referred in an allegro-anesthetic

    Time frame: Outcome is analysed every 2 years over a 10 years period

Study contacts

Contact information is provided by the study sponsor or research team.

Charles TACQUARD, MD

CONTACT

[email protected]

33.3.69.55.16.08

Paul-Michel MERTES, MD, PhD

CONTACT

[email protected]

33 3 69 55 04 44

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

Epidemiological Survey on Perioperative Hypersensitivity Reactions in France by the GERAP Network (Groupe d'étude Des réactions Anaphylactiques périopératoires)

Acronym: SERAP

Important dates

Study start
2020
Primary completion
2031
Study completion
2031
First posted
Dec 4, 2020
Registry last updated
May 3, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.